SMAD3 and glioblastoma: To test whether Akt can suppress the phosphorylation of Smad3 in NAG-1-overexpressed glioblastoma cells, the PI3K inhibitors wortmannin and LY294002 were used to inhibit the Akt phosphorylation, and then the Smad3 phosphorylation was analyzed by western blot.